Selenium-binding protein 1 as a tumor suppressor and a prognostic indicator of clinical outcome

Biomarker Research

Volumn 1, Issue 1, 2013, Pages

  Yang, Wancai ^a,b   Diamond, Alan M ^b  

^a XINXIANG MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Biomarker; Cancer; Glutathione peroxidase 1; Selenium; Selenium binding protein 1

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; SELENIUM BINDING PROTEIN; SELENIUM BINDING PROTEIN 1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL MOTILITY; CELL PROLIFERATION; COLORECTAL CANCER; DISEASE FREE SURVIVAL; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC TRANSFECTION; HUMAN; IMMUNOPRECIPITATION; LUNG ADENOCARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TANDEM MASS SPECTROMETRY; TISSUE MICROARRAY; WESTERN BLOTTING;

EID: 84901933025     PISSN: None     EISSN: 20507771     Source Type: Journal    
DOI: 10.1186/2050-7771-1-15     Document Type: Review

References (31)

1. Group, KDR Epidemiologic studies on the etiologic relationship of selenium and Keshan disease. Chin Med J (Engl) 1979, 92:477-482. Group, KDR.
2. Bellinger FP, Raman AV, Reeves MA, Berry MJ. Regulation and function of selenoproteins in human disease. Biochem J 2009, 422:11-22. 10.1042/BJ20090219, 2912286, 19627257.
3. Greenwald P, Anderson D, Nelson SA, Taylor PR. Clinical trials of vitamin and mineral supplements for cancer prevention. Am J Clin Nutr 2007, 85:314S-317S.
4. Behne D, Kyriakopoulos A. Mammalian selenium-containing proteins. Annu Rev Nutr 2001, 21:453-473. 10.1146/annurev.nutr.21.1.453, 11375445.
5. Kryukov GV, Castellano S, Novoselov SV, Lobanov AV, Zehtab O, Guigo R, Gladyshev VN. Characterization of mammalian selenoproteomes. Science 2003, 300:1439-1443. 10.1126/science.1083516, 12775843.
6. Gladyshev VN, Hatfield DL. Analysis of selenocysteine-containing proteins. Curr Protoc Protein Sci, Chapter 2001, 3:38.
7. Berry MJ, Banu L, Chen YY, Mandel SJ, Kieffer JD, Harney JW, Larsen PR. Recognition of UGA as a selenocysteine codon in type I deiodinase requires sequences in the 3' untranslated region. Nature 1991, 353:273-276. 10.1038/353273a0, 1832744.
8. Driscoll DM, Copeland PR. Mechanism and regulation of selenoprotein synthesis. Annu Rev Nutr 2003, 23:17-40. 10.1146/annurev.nutr.23.011702.073318, 12524431.
9. Hu Y, Benya RV, Carroll RE, Diamond AM. Allelic loss of the gene for the GPX1 selenium-containing protein is a common event in cancer. J Nutr 2005, 135:3021S-3024S.
10. Bansal MP, Oborn CJ, Danielson KG, Medina D. Evidence for two selenium-binding proteins distinct from glutathione peroxidase in mouse liver. Carcinogenesis 1989, 10:541-546. 10.1093/carcin/10.3.541, 2924398.
11. Chang PW, Tsui SK, Liew C, Lee CC, Waye MM, Fung KP. Isolation, characterization, and chromosomal mapping of a novel cDNA clone encoding human selenium binding protein. J Cell Biochem 1997, 64:217-224. 10.1002/(SICI)1097-4644(199702)64:2<217::AID-JCB5>3.0.CO;2-#, 9027582.
12. Porat A, Sagiv Y, Elazar Z. A 56-kDa Selenium-binding Protein Participates in Intra-Golgi Protein Transport. J Biol Chem 2000, 275:14457-14465. 10.1074/jbc.275.19.14457, 10799528.
13. Chen G, Wang H, Miller CT, Thomas DG, Gharib TG, Misek DE, Giordano TJ, Orringer MB, Hanash SM, Beer DG. Reduced selenium-binding protein 1 expression is associated with poor outcome in lung adenocarcinomas. J Pathol 2004, 202:321-329. 10.1002/path.1524, 14991897.
14. Li T, Yang W, Li M, Byun DS, Tong C, Nasser S, Zhuang M, Arango D, Mariadason JM, Augenlicht LH. Expression of selenium-binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer. Mol Nutr Food Res 2008, 52:1289-1299. 10.1002/mnfr.200700331, 18435490.
15. Scortegagna M, Martin RJ, Kladney RD, Neumann RG, Arbeit JM. Hypoxia-inducible factor-1{alpha} suppresses squamous carcinogenic progression and epithelial-mesenchymal transition. Cancer Res 2009, 69:2638-2646. 10.1158/0008-5472.CAN-08-3643, 2756430, 19276359.
16. Jeong J-Y, Wang Y, Sytkowski AJ. Human selenium binding protein-1 (hSP56) interacts with VDU1 in a selenium-dependent manner. Biochem Biophys Res Commun 2009, 379:583-588. 10.1016/j.bbrc.2008.12.110, 19118533.
17. Pass HI, Liu Z, Wali A, Bueno R, Land S, Lott D, Siddiq F, Lonardo F, Carbone M, Draghici S. Gene expression profiles predict survival and progression of pleural mesothelioma. Clin Cancer Res 2004, 10:849-859. 10.1158/1078-0432.CCR-0607-3, 14871960.
18. Huang KC, Park DC, Ng SK, Lee JY, Ni X, Ng WC, Bandera CA, Welch WR, Berkowitz RS, Mok SC, Ng SW. Selenium binding protein 1 in ovarian cancer. Int J Cancer 2006, 118:2433-2440. 10.1002/ijc.21671, 16380993.
19. Kim H, Kang HJ, You KT, Kim SH, Lee KY, Kim TI, Kim C, Song SY, Kim HJ, Lee C, Kim H. Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival. Proteomics 2006, 6:3466-3476. 10.1002/pmic.200500629, 16645984.
20. Pohl NM, Tong C, Fang W, Bi X, Li T, Yang W. Transcriptional regulation and biological functions of selenium-binding protein 1 in colorectal cancer in vitro and in nude mouse xenografts. PLoS One 2009, 4:e7774. 10.1371/journal.pone.0007774, 2774949, 19924303.
21. Silvers AL, Lin L, Bass AJ, Chen G, Wang Z, Thomas DG, Lin J, Giordano TJ, Orringer MB, Beer DG, Chang AC. Decreased selenium-binding protein 1 in esophageal adenocarcinoma results from posttranscriptional and epigenetic regulation and affects chemosensitivity. Clin Cancer Res 2010, 16:2009-2021. 10.1158/1078-0432.CCR-09-2801, 2953959, 20332323.
22. Xia YJ, Ma YY, He XJ, Wang HJ, Ye ZY, Tao HQ. Suppression of selenium-binding protein 1 in gastric cancer is associated with poor survival. Hum Pathol 2011, 42:1620-1628. 10.1016/j.humpath.2011.01.008, 21497372.
23. Zhang J, Dong WG, Lin J. Reduced selenium-binding protein 1 is associated with poor survival rate in gastric carcinoma. Med Oncol 2011, 28:481-487. 10.1007/s12032-010-9482-7, 20354826.
24. Zhang J, Zhan N, Dong WG. Altered expression of selenium-binding protein 1 in gastric carcinoma and precursor lesions. Med Oncol 2010, 28:951-957.
25. Zhang P, Zhang C, Wang X, Liu F, Sung CJ, Quddus MR, Lawrence WD. The expression of selenium-binding protein 1 is decreased in uterine leiomyoma. Diagn Pathol 2010, 5:80. 10.1186/1746-1596-5-80, 3014888, 21143902.
26. Huang C, Ding G, Gu C, Zhou J, Kuang M, Ji Y, He Y, Kondo T, Fan J. Decreased selenium-binding protein 1 enhances glutathione peroxidase 1 activity and downregulates HIF-1alpha to promote hepatocellular carcinoma invasiveness. Clin Cancer Res 2012, 18:3042-3053. 10.1158/1078-0432.CCR-12-0183, 22512980.
27. Stasio DI, Volpe MG, Colonna G, Nazzaro M, Polimeno M, Scala S, Castello G, Costantini S. A possible predictive marker of progression for hepatocellular carcinoma. Oncol Lett 2012, 2:1247-1251.
28. Lamba G, Ambrale S, Lee B, Gupta R, Rafiyath SM, Liu D. Recent advances and novel agents for gastrointestinal stromal tumor (GIST). J Hematol Oncol 2012, 5:21. 10.1186/1756-8722-5-21, 3405472, 22569033.
29. Lamba G, Gupta R, Lee R, Ambrale S, Liu D. Current management and prognostic features for gastrointestinal stromal tumor (GIST). Experimental Hematology & Oncology 2012, 1:14. 10.1186/2162-3619-1-14, 23484729.
30. Fang W, Goldberg ML, Pohl NM, Bi X, Tong C, Xiong B, Koh TJ, Diamond AM, Yang W. Functional and physical interaction between the selenium-binding protein 1 (SBP1) and the glutathione peroxidase 1 selenoprotein. Carcinogenesis 2010, 31:1360-1366. 10.1093/carcin/bgq114, 2915633, 20530237.
31. Jerome-Morais A, Wright ME, Liu R, Yang W, Jackson MI, Combs GF, Diamond AM. Inverse association between glutathione peroxidase activity and both selenium-binding protein 1 levels and gleason score in human prostate tissue. Prostate 2012, 72:1006-1012. 10.1002/pros.21506, 22072582.